- Investing.com
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
Metrics to compare | CHEOY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCHEOYPeersSector | |
---|---|---|---|---|
P/E Ratio | 52.0x | −4.4x | −0.5x | |
PEG Ratio | 5.67 | −0.06 | 0.00 | |
Price/Book | 10.4x | 2.6x | 2.6x | |
Price / LTM Sales | 8.6x | 3.0x | 3.3x | |
Upside (Analyst Target) | - | 100.0% | 40.3% | |
Fair Value Upside | Unlock | 17.0% | 5.1% | Unlock |